You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
As the diagnostics industry launches high-throughput systems to large labs for HbA1c testing, clinicians also see a market need for point-of-care testing.
The test on the Alinity platform is for use in the POC or clinical laboratory setting, and for the quantitative measurement of glucose in arterial and venous whole blood.
Clinical trials show that people who use the system, which eliminates a painful finger stick, test glucose levels an average of 15 times each day.
The first-ever study looking at diabetes in youths in the five major ethnic and racial groups in the US could not determine a reason for the spike in diabetes diagnoses.
The mySugr app will give Canadian users quick access to diabetes data and enable them to synchronize glucose levels with Roche's diabetes management system.
The firm said it is now an in-network provider with the country's fourth-largest health insurer.
The firm launched the service in part because it recognized that consumers increasingly prefer to pay for their healthcare services out of pocket and without having to get physician referrals.
The meta-analysis further suggested that efforts to screen and treat people at risk of developing diabetes might not be effective.
The analyzer is a dedicated instrument for HbA1c analysis that offers twice the throughput of the instrument it replaces.
Roche, Eli Lilly, and others aim to elucidate differences in T2D patients in order to develop better diagnostic tools and new treatments.